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Abstract.  Treatment of F9 teratocarcinoma stem cells 
with retinoic acid (RA) causes their irreversible 
differentiation into extraembryonic endoderm. To elu- 
cidate the role of the cellular retinoic acid binding 
protein-I (CRABP-I)  in this differentiation process, we 
have generated several  different stably transfected F9 
stem cell lines expressing either elevated  or reduced 
levels of functional CRABP-I protein. Stably trans- 
fected lines expressing elevated  levels of CRABP-I ex- 
hibit an 80-90%  reduction in the RA induced expres- 
sion of retinoic acid receptor (RAR)/3, laminin B1, 
and collagen type IV (od) mRNAs at low exogenous 
RA concentrations, but this reduction is eliminated at 
higher RA concentrations. Thus, greater expression of 
CRABP-I reduces the potency of RA in this differenti- 
ation system. Moreover, transfection of a CRABP-I ex- 
pression vector into F9 cells resulted in five- and 
threefold decreases in the activation of the laminin B1 
RARE (retinoic acid response element) and the RAR 
/3 RARE, respectively,  as measured from RARE/CAT 
expression vectors in transient transfection assays. 
These results support the idea that CRABP-I se- 
questers RA within the cell and thereby prevents  RA 
from acting to regulate differentiation specific  gene ex- 
pression. Our data suggest a mechanism whereby the 
level of CRABP-I can regulate responsiveness to RA 
during development. 
ETINOIC acid (RA), ~ a derivative of retinol (vitamin 
A),  influences the proliferation  and cellular  differ- 
entiation of a wide variety of cell types (Sporn and 
Roberts, 1983). For example, RA has been shown to inhibit 
differentiation of keratinocytes  (Fuchs  and Green,  1981), 
and promote differentiation of human promyelocytic leuke- 
mia ceils (Breitman et al., 1980), melanoma cells (Lotan and 
Lotan, 1981), human neuroblastoma  cells (Hanssler et al., 
1983) and mouse teratocarcinoma  stem cells (Strickland et 
al., 1980). In addition, retinoids can suppress or reverse the 
malignant phenotype both in vivo and in vitro (Sporn and 
Newton,  1981; and Lotan, 1980). RA exhibits striking ef- 
fects on vertebrate limb development (Thaller and Eichele, 
1987, Tickle et al.,  1982) and limb regeneration  (Maden, 
1983), lending support to the idea that RA plays a pivotal 
role in pattern formation during development. 
F9 murine teratocarcinoma  stem cells resemble the plu- 
ripotent inner cell mass cells of mouse blastocysts, and thus, 
provide an important model system with which to study criti- 
cal early events in mouse development during the time when 
initial cell lineage commitments are made. F9 mouse terato- 
carcinoma stem cells differentiate into primitive endoderm 
1. Abbreviations used in thispaper: RA, retinoic acid; RACT, retinoic acid 
plus dibutyryl cAMP and theophylline. 
in response to RA and into parietal endoderm, an epithelial 
extraembryonic cell type in the mouse blastocyst, in response 
to RA and dibutyryl cAMP (Strickland et al., 1980). When 
F9 stem cells differentiate, the genes encoding laminin B1 
and collagen IV (cd) are transcriptionally activated between 
24 and 48 h after exposure to RA (Hosler et al., 1989) and 
their mRNA levels become 50-60-fold higher by 60 h (Wang 
et al., 1985). In contrast,  within 2 h after RA addition the 
Era-1/Hox  1.6  gene  is  transcriptionally  activated (LaRosa 
and Gudas,  1988a, b).  (The Era-1 gene appears to be the 
same gene as that named Hox  1.6 by Baron et al.,  1987.) 
Decreases in the expression of specific genes such as c-myc 
(Griep and DeLuca, 1986; Dony et al., 1985; Campisi et al., 
1984) and REX-1 (Hosler et al., 1989) in RA-treated F9 cells 
have also been reported. Thus, these classes of genes repre- 
sent molecular markers of the parietal endoderm differentia- 
tion pathway. 
Although the mechanism whereby RA regulates gene ex- 
pression and differentiation is not completely understood,  it 
is likely that high-affinity RA receptors and/or binding pro- 
teins are involved. Recently, four high-affinity nuclear reti- 
noic acid receptors were identified and shown to be members 
of a large family of genes that encode nuclear steroid hor- 
mone receptors. These four genes, which presumably act as 
transcription factors, have been designated RAR ~, RAR/3, 
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1987; Benbrook et al., 1988; Krust et al., 1989; deThe et al., 
1989; Giguere et al., 1987; Mangelsdorf et al., 1990). RAR 
ct and -y mRNAs are constitutively expressed in F9 stem cells 
whereas the RAR/~ mRNA level increases 20-fold after RA 
addition (Krust et al.,  1989;  Hu and Gudas,  1990). 
In addition to these nuclear RA binding proteins, F9 cells 
express a high-affinity cytoplasmic RA-binding protein des- 
ignated the cellular RA-binding protein (CRABP-I; Erikkson 
et  al.,  1986;  Stoner  and  Gudas,  1989).  Both  the  bovine 
CRABP-I  cDNA  (Shubeita  et  al.,  1987)  and  the  mouse 
CRABP-I cDNA (Stoner and Gudas, 1989) have been cloned 
and sequenced. The mouse CRABP-I gene encodes a single, 
low abundant mRNA species with an approximate length of 
800 nucleotides. The CRABP-I mRNA level decreases two- 
to threefold after treatment of F9-Wt cells with RA alone; 
however, the CRABP-I mRNA level increases 'x,20-fold be- 
tween 24 and 48 h  after treatment with RA plus dibutyryl 
cAMP (Stoner and Gudas, 1989). The mRNA encodes a  15- 
kD  protein that  exhibits  a  high affinity for  RA  (Ka  =  10 
nM, Grippo and Gudas,  1987) and does not appear to con- 
tain  any  DNA  binding motifs.  A  second  mouse  CRABP 
gene, referred to as CRABP-II, has recently been cloned and 
its expression studied during mouse embryogenesis (Giguere 
et al., 1990). The CRABP-II mRNA is expressed at high lev- 
els during early mouse development and in adult mouse skin. 
In addition, CRABP-II mRNA levels are induced 50-fold in 
F9 teratocarcinoma cells treated with RA for 48 h  (Giguere 
et al., 1990). The levels of CRABP-I and CRABP-II mRNAs 
have not been directly compared in F9 cells, so which of the 
genes is predominantly expressed  is unknown. 
CRABP-I mRNA expression has been detected in the de- 
veloping  mouse  nervous  system,  the  eye  region,  and  the 
craniofacial  region  (Perez-Castro  et  al.,  1989).  In mouse 
limb buds,  Dolle  et  al.  (1989)  showed  that  the  CRABP-I 
mRNA was expressed along a proximo-distal gradient with 
maximal expression at the distal portion of the day  10 de- 
veloping mouse limb. This suggests that the CRABP-I may 
play a role in mediating the putative effects of RA during pat- 
tern formation of the limb. It is of interest that the patterns 
of CRABP-I mRNA  expression and those  of RAR/5  and 
RAR  "y  were  mutually  exclusive  at  day  14.5,  suggesting 
different functions for these proteins (Dolle et al.,  1989). 
As yet no function has been defined for  CRABP-I.  Our 
results reported here support the idea that CRABP-I func- 
tions either to sequester RA within the cytoplasm or to en- 
hance the  metabolism of RA to  inactive derivatives,  thus 
limiting the RA specific activation of differentiation-specific 
genes. 
Materials and Methods 
Cell Culture 
Mouse F9 teratocarcinoma stem cells were maintained at 37°C in 10% 
CO2 in tissue flasks with DMEM supplemented with 10% heat-inactivated 
calf serum (Gibco Laboratories, Grand Island, NY) and 2 mM glutamine 
as described previously (Wang et al., 1985). For cell growth experiments, 
1=9 stem cells (2 ×  104 cells) were plated on gelatinized multiwell tissue 
culture plates containing 2 rni of medium. Retinoic acid (Sigma Chemical 
Co., St. Louis, MO) was added 6-8 h after plating (Wang  and Gudas, 1984). 
All RA stock solutions were made in 100% ethanol; the final [ethanol] in 
DMEM was never >1%. Cells were harvested beginning the  following 
morning (day 1) and counted in a Coulter counter (Coulter Electronics, Hia- 
leah, FL). 
Plasmids 
The full-length CRABP-I eDNA (Stoner and Gudas, 1989) was cloned into 
the Eco RI restriction site within the expression vector pMT64AA (Glan- 
ville et al., 1982). This vector contains the mouse metallothionein I pro- 
moter and an Eco RI/Hind III polylinker followed  by a poly-A addition site 
spanning an additional 200 bases. The anti-sense CRABP-I vector was con- 
structed in a similar manner  and contains the CRABP-I eDNA in the reverse 
orientation. The pSV2 neo plasmid (Southern and Berg, 1982) was used as 
a selection marker for the generation of stably transfected cells. The peI56 
plasmid contains a partial eDNA specific for the murine laminin B1 gene 
within the Pst I site ofpBR322 (Wang  and Gudas, 1983). The pcI5 contains 
a partial eDNA specific for the collagen type IV (cd) gene within the Pst 
I site of pBR322 (Wang and Gudas, 1983). The pEra-1-993 El.0 plasmid 
contains the 3' Eco RI fragment of the Era-I/Hox 1.6 eDNA cloned into 
pUC-9 (LaRosa and Gudas, 1988a). The pMT-c-myc  1 plasmid contains the 
c-myc Sac I/Hind [] fragment (Stanton et al., 1984) cloned into the Sma 
I/Hind [] site of pMT64AA. The pact-1 plasmid contains a partial eDNA 
coding for the routine B actin gene (Spiegelman et al., 1983). The pSG5- 
RAR ~ and the pSG5-RAR B plasmids contain the entire protein coding 
regions of the human RAR a  and the human PAR B genes, respectively. 
The RAR a eDNA was cloned into the Eco RI site within pSG5 and the 
human RAR ~ eDNA was cloned into the Eco RI/Bam HI site within pSG5 
(Petkovich et al., 1987; Brand et al., 1988). The REX-1 eDNA was cloned 
into the Eco RI site within pUC9 (Hosler et al., 1989). All vector inserts 
were isolated by the band intercept procedure before random primer label- 
ing (Schleicher & Schuell application update #364,  1981). 
Production and Initial Characterization of  the Growth 
Properties of  Stably Transfected Cell Lines 
All transfections were carried out using the calcium phosphate precipitation 
procedure (Graham and Van der Eb,  1973). Cotransfections were per- 
formed at a I0:1 molar ratio of the gene of interest to the neomycin resis- 
tance gene in pSV2 neo, which was used as a selectable marker. Selection 
was carried out in medium containing 300/~g/ml of G418 sulfate (Gibco 
Laboratories) for 14-21 d.  Resistant foci were subsequently cloned and 
grown up in mass culture for screening for the stable expression of the trans- 
fected gene. Screening G418-resistant clones for the elevated or reduced ex- 
pression of the CRABP-I gene was carried out by the RNA slot blot proce- 
dure as described previously (Schleicher & Schuell application update 372, 
1983). Clones were grown in 100 IzM zinc chloride for 4 d, after which 
cytoplasmic RNA extracts were prepared for slot blotting onto nitrocellu- 
lose sheets. All hybridizations and washing procedures were carried out as 
described (Stoner and Gudas, 1989). Each blot was stripped and reprobed 
with actin to insure that equal amounts of RNA had been blotted. All probes 
were labeled by the random primer  procedure as described previously 
(Feinberg and Vogelstein, 1984). The cell lines characterized in this paper 
are designated as follows: untransfected F9 wild-type stem cells, Fg-Wt; a 
G418-resistant clone of pSV2 neo transfected F9 wild-type stem cells, Fg- 
Wt-S-neo-1;  tv~ CRABP-I sense transfected F9 wild-type stem cell clones 
number 11 and 15, Fg-Wt-S-CRABP-I-11  and F9-Wt-S-CRABP-I-15;  two 
CRABP-I anti-sense transfected F9 wild-type stem cell clones number 18 
and 27, Fg-Wt-AS-CRABP-I-18  and Fg-Wt-AS-CRABP-I-27. 
Growth curves were performed to determine whether alterations in the 
level of CRABP-I mRNA influenced the proliferation of the transfected F9 
lines in the presence or absence of different concentrations of RA, plus 100 
/~M zinc chloride, 250 ~M dibutyryl cAMP, and 500 #M theophylline (CT; 
Sigma Chemical Co.). Drug treatment is abbreviated as RACT to indicate 
the addition of RA plus dibutyryl cAMP and theophylline. Previous experi- 
ments (Dionne, C., unpublished) demonstrated that 100 ~M zinc chloride 
was not toxic to Fg-wt cells, and that this concentration of zinc chloride 
did not influence the RA-assoeiated differentiation of F9 cells. In the ab- 
sence of any drugs, the F9-Wt, F9-Wt-S-neo-1,  CRABF-I sense transfected 
and CRABP-I anti-sense transfected lines exhibited generation times of 
~,14-16 h. In the presence of I  ×  10  -6 M RA, 100 ~M zinc chloride, and 
CT, the generation times were also '~14-16 h for all of the lines (data not 
shown). In the presence of 1 ×  10  4  M RA, 100 ~M zinc chloride, and 
CT, reductions in the growth rates ofail of  the lines were measured; no eyto- 
toxicity was seen, as the cell numbers increased over the 4-d period in all 
of the lines and very few dead cells (<1%) were observed in the wells. 
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Total cellular RNA was isolated by the guanidine isothiocyanate method as 
described previously (Chirgwin et al.,  1979).  RNA was isolated at 0,  12, 
24, 36, 48, and 96 h after addition of  retinoic acid at various concentrations  as 
described in the figure legends; 250/zM dibutyryl cAME 500 #M theophyl- 
line, and 100 ttM zinc chloride were also added to the samples. The combi- 
nation of RA, dibutyryt cyclic AMP, and theophylline is designated RACT 
or RA plus CT.  Time 0 is defined as 6-8 h after trypsinization and plating 
of  the cells. The RNA was size fractionated on 1.2% agarose/2.2 M formal- 
dehyde gels, transferred to nitrocellulose, and hybridized with a random 
primer labeled probe as described previously (Stoner and Gudas,  1989). 
Blots were exposed to Kodak XAR-5 film at  -70°C with an intensifying 
screen. The hybridization signals were quantitated by scanning densitome- 
try using a Helena Laboratories (Beaumont, TX) densitometer linked to an 
automatic integrator. All of  the Northern analyses shown in this manuscript 
were performed at least twice using two different RNA preparations from 
cells cultured from two different thawed vials of each of the cell lines. 
Genomic DNA Isolation and Southern Blot Analysis 
Genomic DNA was isolated from F9 stem cells and F9 clones as described 
(Herrmann and Frischauf, 1987).  Restriction endonuclease digestions and 
Southern blotting  were  carried  out  as  described previously  (Southern, 
1975). The hybridizations were performed as described previously (Stoner 
and Gudas,  1989). 
pH]Retinoic Acid Binding Assay 
The levels of [3H]RA binding in cytoplasmic extracts of F9 stem cells and 
F9 transfectants were measured by the sucrose gradient procedure (Grippo 
and Gudas, 1987) or FPLC chromatography analysis (Nervi et al., 1989). 
Briefly, 400/~g (F9-Wt-S-neo-1 and CRABP-I sense transfectants) or 600/~g 
(CRABP-I anti-sense transfectants) of total  cytoplasmic protein was in- 
cubated in a final volume of 200/~1 in the presence of 2 mM dithiothreitol, 
10 mM Tris, pH 7.4, and 75 nM [3H]RA (specific activity 53-55 Ci/mmol; 
New England Nuclear, Boston, MA). Each sample was incubated in the 
dark at 4"C for 5 h. Two controls consisted of incubating extracts with a 
100-fold  molar excess of unlabeled RA, or 100-fold  molar excess of unla- 
beled retinol (Sigma Chemical Co.).  Unbound [3I-I]RA was removed by 
charcoal extraction. For sucrose gradient analysis, the samples were applied 
to a 4.3-ml gradient of 5-15%  sucrose in PBS and spun at 220,000 g  for 
21 h at 4°C. After centrifugation, 280-1zl fractions were collected from the 
bottom of each tube and counted by liquid scintillation. For FPLC analysis, 
the samples were fractionated over a Superose 12 HR 10/30 size-exclusion 
column (Pharmacia Fine Chemicals, Piscataway,  NJ) at 4°C maintaining a 
flow rate of 0.5 ml/min with PIG buffer (5 mM sodium phosphate, pH 7.4, 
10 mM thioglycerol, and 10% glycerol) plus 0.4 M KCI as the eluent. Each 
0.5-ml fraction was counted by liquid scintillation. 
Transient Transfection and CAT Assay 
The transient transfections and chloramphenicol aceyltransferase (CAT) as- 
says were performed as described (Vasios et al., 1989). Briefly, F9-Wt stem 
cells were cotransfected by the calcium phosphate precipitation method 
with various combinations of the plasmids, as  indicated in the figures; 
pSG5-RAR ot (1  ~g), pMT-CRABP-I-sense (5  #g), pMT-CRABP-I anti- 
sense (5/zg), pL-477/-432 Lain TKCAT (10/~g), pRARB-RARE CAT (10 
#g), pRSV-CAT (10/zg) and varying amounts of pUC9 DNA (to bring the 
total amount of transfected DNA to 20/zg). pL-477/-432 LamTKCAT vec- 
tor contains the laminin B1 RARE (Vasios et al., 1989). The pRARB-RARE 
CAT vector contains the RAR ~ RA responsive element (deTh~ et al., 1990) 
inserted into the Hind III and Barn HI restriction sites of pBLCAT 2. The 
RSV-CAT  vector contains the Rous sarcoma viral  LTR  (Gorman et al., 
1982a)  and was used as an additional control. The p#Ac lacZ (3/~g) con- 
struct was included in all transfections to normalize for any differences in 
transfection  efficiency. The precipitate was removed after 12 h and the cells 
were treated with 100/zM zinc chloride with or without 1 #M RA for 24 
or 48 h. Cells were harvested and extracts were prepared for the CAT assay 
(Herbomel et al.  1984;  Gorman et al.,  1982b).  Protein equivalent to 20 
units of/3-galactosidase activity was used for each CAT assay. Quantitation 
of the monoacetylated [14C]chloramphenicol product was performed by 
liquid scintillation analysis. 
Figure L  Southern blot analysis of CRABP-I sense and CRABP-I 
anti-sense  F9  transfectants.  Genomic  DNA  was  isolated  and 
digested with the restriction enzyme Eco RI. Fragmented DNA was 
fractionated through a  1% agarose gel and transferred to nitrocellu- 
lose. The blot was probed with random primer labeled CRABP-I 
cDNA  (2  x  106 cpm/ml).  DNA/Hind  III  size markers  are  indi- 
cated.  The  0.8-kb  band  corresponds to  the  integrated  CRABP-I 
eDNA insert. The exposure time was 36 h.  This experiment was 
performed twice with identical results. 
Results 
Isolation of  Stably Transfected F9 Cell Lines 
Containing CRABP-I Sense or A nti-sense cDNA 
To determine the function of CRABP-I, we have transfected 
mouse F9 teratocarcinoma stem cells with a  plasmid con- 
taining the mouse full-length CRABP-I eDNA in either the 
sense orientation or in the anti-sense orientation under the 
transcriptional control of the heavy metal inducible mouse 
metallothionein I promoter. F9 stem cells were cotransfected 
with either CRABP-I sense eDNA or CRABP-I anti-sense 
cDNA and the pSV2neo gene followed by selection in G418 
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Figure 2. Sucrose gradient analysis of [3H]RA binding activity in 
undifferentiated F9 stem ceils and CRABP-I transfectants. Cyto- 
plasmic extracts were prepared from F9-Wt-S-neo-1 stem cells, F9- 
Wt-S-CRABP-I-11, F9-Wt-S-CRABP-I-15,  F9-Wt-AS-CRABP-I-18, 
and F9-Wt-AS-CRABP-I-27 grown for 4 d in the presence of 100 
#M zinc chloride in the absence of any media change. Total cyto- 
plasmic protein was incubated with either [3H]RA,  a 100-fold ex- 
cess of nonradioactive RA, or a 100-fold excess of nonradioactive 
retinol. CRABP [aH]RA complexes were assayed by the sucrose 
gradient procedure. Gradients were fractionated and each aliquot 
was counted in a scintillation counter. The results are expressed as 
the total number of [3H]RA counts per minute as a function of 
fraction number. CRABP-RA complexes possess a sedimentation 
coefficient  of  2S. The arrow at the bottom left indicates the direction 
of sedimentation.  Incubation conditions:  (n)  [3H]RA  only;  (zx) 
[3H]RA plus 100-fold excess nonradioactive retinol; (m) [3H]RA 
plus 100-fold excess nonradioactive RA. The experiments repre- 
sented in the top three panels were carried out with 400 ~g total 
cytoplasmic protein while those in the bottom three panels were 
performed with 600 t~g total cytoplasmic protein. The top and bot- 
tom panels have different y-axes. Each experiment was performed 
twice  using cytoplasmic extracts  from cells cultured  from  two 
different thawed vials of each of the cell lines. 
sulfate. G418-resistant colonies were isolated and screened 
by the RNA slot blot procedure for either the elevated ex- 
pression of CRABP-I mRNA in the case of the sense trans- 
fectants or for the decreased expression of CRABP-I mRNA 
in the case of the anti-sense transfectants. For the CRABP-I 
sense transfectants,  we  identified 3  stably transfected cell 
lines out of 25  that expressed a  higher level of CRABP-I 
mRNA  as compared to the F9  stem  cell control.  For the 
CRABP-I anti-sense transfectants, we identified 4 clones out 
of 28 that appeared to exhibit a decreased level of CRABP-I 
mRNA.  Two  CRABP-I  sense-transfected  lines,  F9-Wt-S- 
CRABP-I-11 and F9-Wt-S-CRABP-I-15, and two CRABP-I 
anti-sense transfected lines, F9-Wt-AS-CRABP-I-18 and F9- 
Wt-AS-CRABP-I-27, were chosen for further analysis. 
Southern Analysis of Stably Transfected Lines 
Southern blot analysis revealed the typical genomic restric- 
tion pattern for the endogenous  CRABP-I gene  within F9 
stem cells (Stoner and Gudas,  1989) characterized by three 
Eco RI restriction fragments of 22, 5.6,  and 4.9 kb (Fig.  1). 
These three Eco RI fragments were present in all of the F9 
transfectants  in  addition to  several other  restriction frag- 
ments created by the random integration of the transfected 
CRABP-I cDNA.  Most notable was a  0.8-kb Eco RI frag- 
ment  which  corresponded to  the  0.8-kb  CRABP-I  cDNA 
contained  within  the  transfected  plasmid  DNA  (Fig.  1). 
These results indicate that each transfected line is unique and 
that two lines did not arise from the same transfected cell. 
In addition, each transfected line contains at least one exoge- 
nous CRABP-I cDNA of the correct nucleotide length. 
Analysis of the CRABP-I mRNA and the Functional 
CRABP Protein in the Stably Transfected Lines 
RNA from untreated F9-Wt stem cells and from the lines F9- 
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Figure 3. FPLC analysis of [3H]RA binding activity in Fg-Wt-S- 
neo-1 and F9-Wt-S-CRABP-I-15  after the addition of RACT. Cyto- 
plasmic extracts of F9-Wt-S-neo-I and Fg-wt-S-CRABP-I-15 ceils 
were prepared at the indicated times after the addition of RACT 
plus zinc chloride and incubated with either [3H]RA or a  100-fold 
excess of nonradioactive RA.  CRABP  [3H]RA  complexes were 
assayed by FPLC chromatography. Each fraction was counted in 
a  scintillation counter and the level of CRABP [3H]RA binding 
was determined. The results are expressed as the number of femto- 
moles  [3H]RA  bound/milligram protein as  a  function  of time. 
Symbols: (i) F9-Wt-S-neo-1;  (D) Fg-wt-S-CRABP-I-15. This ex- 
periment was performed twice. 
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on Northern blots. The transfected CRABP-I sense mRNA 
could  be  distinguished  from  the  endogenous  CRABP-I 
mRNA by the fact that the transfected CRABP-I transcript 
was 200 nucleotides longer than the endogenous CRABP-I 
transcript as a result of a 200-bp polylinker-poly A addition 
sequence downstream of the CRABP-I eDNA. Therefore, on 
Northern blots the transfected CRABP-I mRNA in F9-Wt-S- 
CRABP-I-11  and F9-Wt-S-CRABP-I-15 was  1,000  nucleo- 
tides,  whereas the endogenous CRABP-I mRNA was 800 
nucleotides  (data not shown). 
Both sucrose gradient assays (Grippo and Gudas,  1987) 
and FPLC assays (Nervi et al., 1989) were used to compare 
the overall increase or decrease in CRABP functional pro- 
tein in the specific transfected lines with the levels in untrans- 
feeted F9-Wt cells and the F9-Wt-S-neo-1 line. These assays 
measure CRABP protein derived from both the endogenous 
CRABP-I gene and the transfected CRABP-I eDNA as well 
as the CRABP-II gene.  Nuclear retinoic acid receptors are 
not detected in these assays, as primarily cytoplasmic protein 
is present in the extracts. Moreover, the nuclear RA receptor 
protein levels are extremely low in F9 cells; as a result, no 
pH]RA binding can be detected when nuclear protein ex- 
tracts of F9 cells are prepared and assayed on sucrose gra- 
dients (Gold, J., unpublished). 
Cytoplasmic protein extracts were prepared from untrans- 
fected F9 stem cells and from the transfected stem cell lines 
after all of the lines were grown in the presence of 100 #M 
zinc chloride for 4 d in the absence of RACT. The control 
extracts, prepared from the F9-Wt-S-neo-1 line, bound 604 
fmol of RA/mg protein in the sucrose gradient assay (Fig. 
2). This is in agreement with previous results using untrans- 
fected F9 stem cells (Grippo and Gudas,  1987).  This level 
of [3H]RA binding  remained the  same in the presence of 
100-fold excess of nonradiolabeled retinol, but the [3H]RA 
binding was effectively eliminated  when extracts were in- 
cubated in the presence of  a 100-fold excess of  nonradioactive 
retinoic  acid.  F9-Wt-S-CRABP-I-11  extracts  bound  1,743 
fmol of RA/mg protein, a level approximately three times the 
level of the control, whereas extracts of the second CRABP-I 
sense  clone,  F9-Wt-S-CRABP-I-15,  bound  5,150  fmol  of 
RA/mg protein,  almost 10 times the  level detected in the 
control  extracts  (Fig.  2).  This  [3H]RA  binding  in  both 
transfected lines was not competed by the presence of a 100- 
fold excess of nonradiolabeled retinol but was abolished by 
the presence of a  100-fold excess of nonradiolabeled RA. 
Very  similar  results  were  obtained  using  a  Superose  12 
column/FPLC assay; the F9-Wt-S-neo-1 line exhibited 561 
+  65 fmol of RA/mg protein and the F9-Wt-S-CRABP-I-15 
line bound 4,967  +  258 fmol of RA/mg protein when these 
lines were grown for 4 d in the presence of 100 #M zinc chlo- 
ride,  whereas  the  F9-Wt-S-neo-1  line  bound  532  fmol of 
RA/mg protein and the F9-Wt-s-CRABP-15 line bound 1,004 
fmol of RA/mg protein when the lines were grown for 4 d 
without zinc chloride. Therefore, F9 stem cells stably trans- 
fected with the CRABP-I sense eDNA under the transcrip- 
tional control of the mouse metallothionein I promoter ex- 
hibited elevated levels of functional CRABP protein. 
Sucrose gradient analysis was also performed on extracts 
prepared from the CRABP-I anti-sense cell lines. 600 ttg of 
total cytoplasmic protein from each line was used to detect 
any reduction in [3H]RA binding in the anti-sense transfec- 
tants.  The control F9-Wt-S-Neo-1 extracts bound 624 fmol 
of RA/mg protein (Fig.  2).  In contrast,  neither of the two 
CRABP-I anti-sense lines, F9-Wt-AS-CRABP-I-18 or F9-Wt- 
AS-CRABP-I-27,  showed  any  detectable  [3H]RA  binding 
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Figure 4.  Northern  blot analysis 
of early RA genes. Total cellular 
RNA (35 #g) was isolated at the 
indicated times after addition of 1 
×  10  -6  M  RA,  CT  plus  zinc 
chloride  and  fractionated  on  a 
1.2% agarose/formaldehyde gel. 
The RNA was transferred  to ni- 
trocellulose  and  probed  with  a 
random  primer  labeled  eDNA 
probe for either ERA-1/Hox 1.6 or 
RAR  B  (1  x  10  6 cpm/ml  and 
2  x  10  6 cpm/ml, respectively). 
The relative mRNA levels are ex- 
pressed  in arbitrary  units deter- 
mined by densitometry  scanning 
of the Northern gels followed by 
normalization  of the ERA-1/Hox 
1.6 and RAR B mRNA level to the 
actin mRNA level for each sam- 
ple.  These  results are expressed 
in relative RNA units. Symbols: 
(s)  F9-Wt; (A)  F9-Wt-S-neo-1; 
(n)  F9-Wt-S-CRABP-I-11;  (zx) 
F9-Wt-S-CRABP-I-15;  (×)  F9- 
Wt-AS-CRABP-I-18; (o) F9-Wt- 
AS-CRABP-I-27.  This  experi- 
ment was performed three times; 
one Northern  analysis is shown. 
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to measure [3H]RA binding and more precisely determine 
the reduction in CRABP functional protein in the F9-Wt-AS- 
CRABP-I-18 and F9-Wt-AS-CRABP-I-27 lines.  From this 
analysis, we estimate that extracts from these two lines ex- 
press >20-fold less CRABP functional protein than the con- 
trol F9-Wt-S-neo-1  extracts (data not shown). 
A time-course experiment was then carried out to examine 
the levels of CRABP protein in F9 stem ceils and the F9-Wt- 
S-CRABP-I-15 transfectant after RACT addition (Fig.  3). 
Cells were treated with RACT plus 100/~M zinc chloride at 
day 0,  and cytoplasmic extracts were prepared at specific 
times thereafter. The CRABP protein levels in the F9-Wt-S- 
neo-1 line rose slowly after drug addition from 13 fmol of 
RA/mg protein at  12 h  to  128  fmol of RA/mg protein at 
96 h. In the CRABP-I sense transfectant, the CRABP pro- 
tein levels increased from 173 fmol of  RA/mg protein at 12 h 
after drug addition to 711 fmol of RA/mg protein at 96 h. 
Thus, the CRABP protein level was 20-25-fold higher at the 
time of drug addition (0 h), and 10-fold higher at 12 h after 
drug addition in the F9-Wt-S-CRABP-I-15 line as compared 
with the F9-W-S-neo-1  line (Fig. 3). By 96 h after addition 
of RACT plus zinc, the F9-Wt-S-CRABP-I-15 line exhibited 
a CRABP protein level that was 5-7-fold higher than that in 
the F9-Wt-S-neo-1  line. It is important to note that in all of 
the  lines  tested,  the  total  number  of femtomoles of RA 
bound/mg protein at 96 h  after RACT addition in Fig.  3 
differs from the total number of femtomoles of RA bound/ 
mg protein at 96 h in the absence of RACT in Fig. 2. One 
possible explanation maybe that the stability of the CRABP 
protein is reduced in the presence of RACT in all of the cell 
lines. However, at the time of RACT addition, the CRABP-I 
sense transfectant possesses much more functional CRABP 
protein than the "control" line F9-Wt-S-neo-1. 
The Effect of  Altered CRABP-I Expression on 
Differentiation-specific  Gene Expression 
To examine whether an elevated level of CRABP-I influences 
the differentiation process of F9 teratocarcinoma cells, the 
expression of  three classes of genes was examined. These in- 
clude primary response (cycloheximide insensitive) mRNAs 
induced within the first 12 h of differentiation, namely Era- 
1/Hox 1.6 and the nuclear RA receptor RAR/5, genes that 
exhibit reduced expression during the first 12-18 h after RA 
addition such as c-myc gene and REX-l, and genes that ex- 
hibit increased expression between 24 and 48 h  after RA 
treatment such as laminin B1 and collagen type IV (cd). 
RNA was isolated from F9-Wt and F9-Wt-S-neo-1  control 
lines, F9-Wt-S-CRABP-I-11  and F9-Wt-S-CRABP-I-15 sense 
transfectants,  and  F9-Wt-AS-CRABP-I-18  and  F9-Wt-AS- 
CRABP-I-27 anti-sense transfectants at 12-h intervals through 
96 h after the addition of RACT (IRA]  =  1 ×  10  -6 M) and 
100 #M zinc chloride. The ERA-1/Hox 1.6 mRNA levels in 
the CRABP-I sense anti-sense transfectants were similar to 
those in identically treated F9-Wt and F9-Wt-S-neo-1  cells 
(Fig. 4). In marked contrast, RAR/3 mRNA levels were not 
detectably induced in response to RACT in the F9-Wt-S- 
CRABP-I-11  and  F9-Wt-S-CRABP-I-15 transfectants (Fig. 
4), whereas the RAR/3 mRNA levels increased 20-fold at 
36 h in the F9-Wt and F9-Wt-S-neo-1,  as observed previously. 
In the CRABP-I anti-sense transfectants, RAR/3 mRNA ex- 
pression was not altered relative to identically treated F9-Wt 
and F9-Wt-S-neo-1  cells (Fig. 4). 
The steady state levels of both REX-1 and c-myc mRNAs 
in F9-Wt and F9-Wt-S-neo-1  cells decreased between 0 and 
12 h after RACT treatment. In the CRABP-I sense as well 
as in the CRABP-I anti-sense transfectants, a similar decline 
in REX-1 and c-myc mRNA levels was observed in the pres- 
ence of 1  x  10  -~ M  RA plus CT (data not shown). 
The steady-state levels of laminin B1 and collagen type IV 
(cd) mRNAs increased '~60-fold in F9-Wt and F9-Wt-S-neo- 
1 cells by 96 h after RACT addition (Fig. 5, A and B): In 
contrast, the expression of laminin B1 and collagen type IV 
(otl)  mRNAs  in  the  F9-Wt-S-CRABP-I-11  and  F9-Wt-S- 
CRABP-I-15 transfectants increased <15-fold by 96 h after 
RACT addition. In the CRABP-I anti-sense lines F9-Wt-AS- 
CRABP-I-18 and F9-Wt-AS-CRABP-I-27, laminin B1,  and 
collagen type IV (od)  steady-state mRNA levels increased 
•60-fold  in response to RACT, an increase of a magnitude 
similar to that in RACT treated F9-Wt and F9-Wt-S-neo-1 
cells. 
In  summary,  transfected  F9-Wt  cell  lines  that  display 
elevated levels of CRABP-I sense transcripts and protein ex- 
hibited marked differences in their levels of expression of 
specific  differentiation  associated  genes  as  compared  to 
identically treated  untransfected F9-Wt ceils  or  F9-Wt-S- 
neo-1 cells. One rapidly RA induced gene, RAR 13, was ex- 
pressed  at  a  greatly  reduced  level  in  both  the  F9-Wt-S- 
CRABP-I-11  and F9-Wt-S-CRABP-I-15.cell lines while the 
mRNA levels of another rapidly induced gene, Era-1/Hox 
1.6,  were  only  marginally  affected  by  the  elevation  in 
CRABP-I. In addition, two genes expressed at later times af- 
ter RACT addition, laminin B1 and collagen type IV (cd), 
were not expressed at levels as high as those observed in the 
RACT treated F9-Wt and F9-Wt-S-neo-1  cells. The decrease 
in functional CRABP-I protein in the CRABP-I anti-sense 
transfectants did not affect the RACT (I  x  10  -6 M RA) in- 
duced expression of the differentiation-specific genes exam- 
ined in these studies. 
Effects of Different Concentrations of  RA 
on the Expression of  Differentiation-speciJic Genes 
in CRABP-I Sense and CRABP-I 
Anti-Sense Transfectants 
The above results support the hypothesis that CRABP-I func- 
tions, at least in part, to sequester intracellular RA. In this 
capacity CRABP-I may act to regulate the concentration of 
cytoplasmic RA and/or regulate the delivery of  RA to the nu- 
clear RA receptors. If this is indeed the case, it should be 
possible to reduce or eliminate the effect of overexpression 
of CRABP-I by increasing the concentration of RA used to 
initiate differentiation. To test this possibility, cells were har- 
vested at 36 or 72 h after the addition of varying concentra- 
tions of RA (plus CT) and the expression of the differentia- 
tion-specific genes was monitored by Northern analysis. 
After addition of 1  ×  10  -8 M RA or 1 ×  10  -~ M RA for 
36 h, the magnitude of the RAR/3 mRNA induction was re- 
duced in the two CRABP-I sense transfectants relative to the 
F9-Wt and Fg-Wt-S-neo-1  lines (Fig. 6, A and B). However, 
after addition  of 1  ×  10-'  M  R.A, the  levels of RAR  13 
mRNA were similar for the four cell lines, Fg-Wt, Fg-wt-s- 
neo-1,  F9-Wt-S-CRABP-I-11,  an F9-Wt-S-CRABP-I-15. 
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At all RA concentrations examined at the 36-h time point, 
the levels of Era-1/Hox 1.6 mRNA were similar in the F9-Wt, 
F9-Wt-S-neo-1, and the two CRABP-I sense transfectants F9- 
Wt-S-CRABP-I-11 and F9-Wt-S-CRABP-I-15, and these lev- 
els increased with increasing RA concentrations (Fig. 6 A). 
Figure 5.  Northern blot analysis 
of late  RA  induced  genes.  (A) 
Northern blot analysis  was  car- 
ried out as described for Fig.  4. 
The random primer radiolabeled 
probes used in the hybridizations 
were laminin BI and collagen IV 
(cd)  cDNAs  (1  x  106  cpm/ml 
and 1 x  106 cpm/ml, respective- 
ly). Densitometry results are ex- 
pressed  in  relative  RNA  units. 
(A) Symbols: (m) F9-Wt; (A) F9- 
Wt-S-neo-l; (D) F9-Wt-S-CRABP- 
1-11;  (zx) F9-Wt-S-CRABP-I-15; 
(x)  F9-Wt-AS-CRABP-I-18;  (o) 
F9-Wt-AS-CRABP-I-27. This ex- 
periment  was  performed  three 
times;  an  autoradiogram  of the 
lamin  B1  Northern  blot  is  also 
shown (B). 
The  RA dose-dependent  expression  of Era-1/Hox  1.6  and 
RAR 13 mRNAs in the two CRABP-I anti-sense transfectants 
was similar to that in identically treated F9-Wt and F9-Wt-S- 
neo-1  control cells  (Fig.  6  A). 
The steady-state levels of REX-1 mRNA in the absence of 
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and  late  RA  induced genes  at 
varying  RA  concentrations.  (A 
and B)  Total cellular RNA (35 
#g) was isolated at 36 h after the 
addition of 1 x  10  -~ M RA, 1 × 
10  -6 M RA, or 1 ×  10  -s M RA, 
plus  250  #M  dibutyryl cAMP, 
500  /~M  theophylline,  and  100 
/~M zinc chloride.  The Northern 
blot was prepared as described in 
the Materials  and Methods.  The 
hybridization probes were radio- 
labeled ERA-1/Hox 1.6 and RAR 
B cDNAs (1  ×  10  6 and 2  x  10  6 
cpm/ml, respectively). Densitom- 
etry results are expressed in rela- 
tive RNA units after normaliza- 
tion to the actin mRNA in each 
sample. (B) An autoradiogram of 
some of the RNA samples hybrid- 
ized to the RAR B cDNA is also 
shown. This blot was subsequently 
stripped  and reprobed  with actin 
(1  x  106 cpm/ml) to quantitate 
the relative levels of RNA in each 
lane.  Fg-wt (lane 1),  Fg-wt-s- 
neo-1 (lane 2), F9-Wt-S-CRABP- 
1-11 (lane 3), F9-Wt-S-CRABP-I- 
15  (lane 4).  (C)  Total  cellular 
RNA (35 ttg) was isolated at 72 h 
after  the  addition of  1  x  10  -~ 
MRA, 1 x  10-~MRA, or 1 x 
10  -8 M RA, plus 250/~M dibu- 
tyryl cyclic AMP, 500/~M theo- 
phylline, and 100 #M zinc chlo- 
ride.  Northern blot analysis was 
performed  as  described in Ma- 
terials and Methods. The hybrid- 
ization probes were radiolabeled 
laminin BI and collagen IV (txl) 
cDNAs (1 x  106 cpm/ml for both). 
Densitometry values are expressed 
in relative  RNA units after nor- 
malization to the actin mRNA in 
eachsample. Symbols for A and C: 
(i)  F9-Wt;  (m)  Fg-Wt-S-neo-1; 
(D)  Fg-wt-S-CRABP-I-I1;  (D) 
F9-Wt-S-CRABP-I-15;  (m)  F9- 
Wt-AS-CRABP-I-18; (=) F9-Wt- 
AS-CRABP-I-27. This experiment 
was performed  twice. 
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anti-sense expression on the activation of the 
laminin B1 RA response element by RAR c~ in 
F9-Wt cells. (A and B) F9-Wt stem cells were 
cotransfected with the indicated plasmids (see 
Materials and Methods) and treated with  100 
#M  zinc  chloride  with  or without  1  x  10  -6 
M  RA for 48 h.  Extracts were prepared and a 
volume of extract containing 20 units of/~-ga- 
lactosidase activity was assayed for CAT activ- 
ity (see Materials and Methods).  This experi- 
ment was performed three times with similar 
results; one experiment is shown. 
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F9-Wt-S-CRABP-I-15  lines. F9-Wt  and F9-Wt-S-CRABP-I-15  stem 
ceils were cotransfected with the indicated plasmids and treated 
with 100 #M zinc chloride with or without 1 x  10  -6 M RA for 
48 h.  Extracts were prepared and CAT assays performed as de- 
scribed in Materials and Methods. This experiment was performed 
twice with similar results; one assay is shown. 
drugs were elevated by two- to threefold in the  CRABP-I 
sense transfectants relative to the F9-Wt and the F9-Wt-S- 
neo-1 control lines at 72 h (data not shown). This suggests 
that small amounts of RA derived from the calf serum may 
continually reduce the REX-1  steady-state mRNA level  in 
the F9-Wt stem cells and that this does not occur to as great 
an extent in the two sense transfectants.  The concentration 
of RA taken up by the cells from the serum is apparently not 
high enough to cause cell differentiation. In the presence of 
varying RA concentrations (plus  CT),  the  REX-1  mRNA 
levels were also two- to threefold higher in the sense transfec- 
tants than in the F9-Wt control line at 72 h (data not shown). 
The reduction of REX-1  mRNA in response to RA in the 
CRABP-I anti-sense transfectants was similar to that in iden- 
tically treated F9-Wt and F9-Wt-S-neo-1  cells lines at doses 
of RA between  10  -8 and  10  -4 M  (data not shown).  Addi- 
tionally,  the levels of c-myc mRNA declined after RACT ad- 
dition to a similar extent in both F9-Wt and the CRABP sense 
and anti-sense transfectants (data not shown). 
At both  1  x  10  -8 M  RA plus CT and  1  x  10  -6 M  RA 
plus CT, laminin B1 and collagen type IV (od) mRNA levels 
were significantly lower in the F9-Wt-S-CRABP-I-11  and F9- 
Wt-S-CRABP-I-15 lines than in the identically treated F9-Wt 
and F9-Wt-S-neo-1  lines.  In striking contrast,  at  1  x  10  -4 
M RA plus CT, the levels of collagen type IV (od) and lami- 
nin B1 mRNAs in the two CRABP-I sense transfectants were 
very similar to the identically treated F9-Wt and F9-Wt-S- 
neo-1 cells (Fig.  6 C). Thus, the inhibition of differentiation 
associated with CRABP-I overexpression can be reversed at 
high exogenous RA concentrations. The RA dose-dependent 
expression of laminin BI and collagen type IV (od) mRNAs 
in the two CRABP-I anti-sense transfectants was similar to 
that in identically treated F9-Wt and F9-Wt-S-neo-1  control 
cells (Fig.  6  C). 
Effect of CRABP-I Overexpression on the Activation 
of the Laminin B1 Gene 
The next question we addressed was whether the reduction 
in the RA-associated laminin B1  mRNA expression in the 
Figure 9.  Effect of CRABP-I and  CRABP-I 
anti-sense expression on the activation of the 
RAR ~ RA responsive element. F9-Wt  and F9- 
Wt-S-CRABP-I-15 stem cells were cotrans- 
fected with the indicated plasmids and treated 
with 100/zM zinc chloride with or without 1 
X  10  -6 M  RA for 48 h.  Extracts were pre- 
pared and CAT assays performed as described 
in  Materials  and  Methods.  This experiment 
was performed twice with similar results; one 
assay is shown. 
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transcriptional activation of the laminin B1  gene.  The pL- 
477/-432  LamTKCAT construct contains the laminin B1  5' 
flanking 46 bp RARE and has been shown to activate CAT 
expression in the presence of RA when cotransfected with 
RAR ot (Vasios et al.,  1989).  F9-Wt cells were transfected 
with either the pMT-CRABP-I sense or pMT-CRABP-I anti- 
sense construct, pSG-5-RAR or, and the pL-477/-432 Lam- 
TKCAT reporter construct, followed by treatment with 100 #M 
zinc  chloride with or without  1  x  10  -6 M  RA for 24 or 
48 h. The presence of the pMT-CRABP-I sense construct re- 
sulted in a two- to threefold reduction in CAT activity at 24 h 
(data not shown) and a five- to sixfold reduction in CAT ac- 
tivity at 48 h when compared to the CAT activity in extracts 
from cells transfected with pSG5-RAR ~  and pL-477/-432 
LamTKCAT without the pMT-CRABP-I vector (Fig.  7 A). 
Thus, transactivation of the laminin B1 RARE by RAR ot is 
reduced in the presence of high CRABP-I levels. 
Transfection  of the  pMT-CRABP-I anti-sense  construct 
with pSG5-RAR a  and pL-477/-432 LamTKCAT did not re- 
sult in any reduction in CAT activity when compared with 
the CAT activity in extracts from cells transfected only with 
pSG5-RAR o~ and pL-477/-432 LamTKCAT when 1 x  10  -6 
M RA was used (Fig. 7 A). Thus, the reduction in LamTK- 
CAT expression observed when  the pMT-CRABP-I sense 
construct is cotransfected is not the result of the titration of 
transcription  factors  by  the  metallothionein  I  promoter. 
Transfection of the pMT-CRABP-I vector plus the pL-477/ 
-432 LamTKCAT vector without the pSG5-RAR ~  resulted 
in no increase in CAT activity (Fig. 7 A), demonstrating that 
the  CRABP-I protein  itself does not  functionally  activate 
transcription through the laminin B1 RARE. As control for 
any potential nonspecific effects of CRABP-I expression in 
the  transient  transfection  assays,  a  RA-unresponsive pro- 
moter,  RSV,  was  employed.  Transient  transfection  of the 
pMT-CRABP-I sense construct, pSG5-RAR ~, and the RSV- 
CAT expression vector followed by treatment with or without 
1  x  10  -6 M  RA did not result in any change in CAT activ- 
ity as compared to a similar transfection without the pMT- 
CRABP-I construct (Fig.  7 B). 
The transient transfection assays described above all in- 
volve introduction of expression vectors into the F9-Wt cells. 
The next series of experiments were performed to compare 
the activation of the laminin B1 RARE by RAR a  +  RA in 
the untransfected F9-Wt control cells with the activation of 
this RARE in the F9-Wt-S-CRABP-I-15 line. Both cell lines 
were transfected with pL-477/-432 LamTKCAT and pSG5- 
RAR or, and the lines were cultured for 48 h in the presence 
of  1  x  10  -6  M  RA  and  100  #M  zinc  chloride.  Extracts 
were then prepared and CAT assays were performed. The 
CAT activity from the F9-Wt-S-CRABP-I-15 extracts was in- 
creased  1.9-fold by RA,  whereas in the F9-Wt extract the 
CAT activity was increased 8.3-fold by RA (Fig.  8). These 
results are consistent with those reported in Fig. 7, and dem- 
onstrate that stable overexpression of the CRABP-I also re- 
sults in decreased activation of the laminin B1  RARE. 
Effect of CRABP-I Overexpression  on the Activation 
of the RAR /Y RARE 
A RA-responsive element (RARE) was recently found in the 
RAR ~  5' flanking DNA (deTh~ et al.,  1990). This RARE 
differs from the laminin B1 RARE in that the RAR/~ RARE 
can be activated by RA in F9 cells without cotransfection of 
the RARs (Fig. 9). Experiments similar to those reported in 
Figs. 7 and 8 were performed, but with the RAR/3 RARE. 
In the first series of experiments, the F9-Wt stem cells were 
transfected with the RAR/~ RARE/TKCAT vector  5:  the 
pMT-CRABP-I vector. The F9-Wt cells were then cultured 
with or without 1 x  10-6 M RA plus 100 #M zinc chloride 
for 48 h.  The introduction of CRABP-I eDNA into F9-Wt 
cells by transient transfection resulted in a threefold reduc- 
tion in CAT activity (Fig.  9). 
In a  second series of experiments, designed to compare 
the responses of the F9-Wt cells with those of the F9-Wt-S- 
CRABP-I-15 line, both lines were transfected with the lIAR 
/3 RARE/TKCAT construct and then cultured with or with- 
out  1  x  10  -6  M  RA  plus  100  #M  zinc  chloride  48  h. 
Again, 3.5-fold less CAT activity was observed in the pres- 
ence  of higher  levels  of CRABP-I  when  the  high  levels 
resulted from stable integration of the exogenous CRABP-I 
eDNA into the chromosomal DNA of the F9-Wt-S-CRABP- 
1-15 line (Fig.  9). 
Effects of  a Reduction in CRABP-I 
Expression on the Activation of the Laminin B1 Gene 
and the RAR /~ RARE 
Overexpression of the CRABP-I protein leads to a reduction 
in the differentiation ofF9 cells in response to exogenous RA 
concentrations ranging from 1 ×  10  -8 to' 1 ×  10  -6 M (Figs. 
4-9).  At these  concentrations  of RA,  the  CRABP-I anti- 
sense transfected lines exhibit no detectable differences from 
F9-Wt in the magnitude of their expression of differentiation- 
specific genes (Figs. 4; 5, A and B; 6, A and C; 7 A; 9). How- 
ever, as the CRABP-I anti-sense transfectants express much 
less CRABP-I protein than Fg-Wt (Fig. 2), we reasoned that 
the antisense transfectants might be more responsive to RA 
than Fg-wt at very low external RA concentrations.  Under 
these conditions, we predict that most or all of the intracellu- 
lar RA would be sequestered by the CRABP-I in F9-Wt cells, 
whereas in the CRABP-I anti-sense transfectants, some RA 
would still be available for interaction with the nuclear RA 
receptors leading to the activation of differentiation specific 
genes. 
Therefore, to compare the responses of the F9-Wt-S-neo-1 
control line and the F9-Wt-AS-CRABP-I-27 line to lower ex- 
ternal RA concentrations, both lines were transfected with 
pL-477/-432  LamTKCAT and  pSG5-RAR  c~.  One  of the 
CRABP-I  sense  transfectants,  F9-Wt-S-CRABP-I-15,  was 
also included in these experiments for comparison. These 
lines were subsequently cultured for 48 h in the presence of 
varying exogenous RA concentrations from 1  x  10  -~o M to 
1  x  10  -7 M  and 100 #M zinc chloride. Extracts were pre- 
pared and CAT assays were then performed. The CAT activi- 
ties of the F9-Wt-AS-CRABP-I-27 extracts were 6.5- and 3.8- 
fold higher  than  those  of the  F9-Wt-S-neo-1  line  at  1  x 
10  -~° M  and  1  x  10  -9 M  RA,  respectively (Fig.  10 A). At 
1  x  10  -s M  and 1  x  10  -7 M  RA, the CAT activities of the 
F9-Wt-S-neo-1  and  F9-Wt-AS-CRABP-I-27 lines  were ap- 
proximately equivalent (Fig.  10 A).  We conclude that the 
CRABP-I anti-sense transfectant is more responsive than the 
F9-Wt-S-neo-1 line to low external RA concentrations (1  x 
10  -1°,  1  X  10  -9  M  RA).  By  comparison,  the  CRABP-I 
sense transfectant exhibited less CAT activity than the F9- 
Boylan and Gudas CRABP-I  Decreases Retinoic Acid Differentiation  975 Figure  10.  The  activation of 
the laminin  B1 RARE and RAR 
RARE in the F9-Wt-S-neo- 
1,  F9-Wt-S-CRABP-I-15,  and 
F9-WT-AS-CRABP-I-27 lines 
at varying RA concentrations. 
(A  and  B)  F9-Wt,  F9-Wt-S- 
CRABP-I-15,  and  F9-Wt-AS- 
CRABP-I-27 stem cells were 
cotransfected  with  the  indi- 
cated  plasmids  and  treated 
with  100  #M  zinc  chloride 
with or without varying doses 
of RA  (1  x  10-1°-1  ×  10  -7 
M)  for  48  h.  Extracts  were 
prepared and CAT assays per- 
formed as described in Mate- 
rials and Methods. 
Wt-S-neo-1 line over the entire range of RA concentrations 
tested (Fig.  10 A). 
In a  second experiment,  the  same three cell lines were 
transfected with  the RAR/3  RARE/TKCAT construct and 
then cultured in the presence of varying exogenous RA con- 
centrations plus zinc chloride for 48 h. Again, 3.3- and 2.5- 
fold  higher  CAT  activities  were  seen  in  the  F9-Wt-AS- 
CRABP-I-27 extracts than in the F9-Wt-S-neo-1 extracts at 
1  ×  10  -1° M  and 1  ×  10  -9 M  R.A, respectively (Fig. 10 B). 
Even at  1  ×  10  -s and  1  ×  10  -7 M  RA, the CRABP-I anti- 
sense transfectant exhibited CAT activities that were ,ol.7- 
fold greater than those of the F9-Wt-S-neo-1 line (Fig. 10 B). 
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CAT activity than the F9-Wt-S-neo-1  line over the range of 
RA concentrations tested (Fig.  10 B). 
In conclusion, the RA-dependent transcriptional activa- 
tion of both the laminin B1 gene and the RAR/3 gene is in- 
versely correlated with the level of CRABP-I protein in the 
cells (Figs. 7-10). 
Discussion 
There has been much speculation about the function of the 
CRABP-I protein, and about whether this protein is present 
in the nucleus.  Some researchers have suggested that the 
CRABP-I facilitates RA action by transporting RA to the nu- 
cleus, whereas others have proposed that the CRABP-I se- 
questers RA in the cytoplasm and/or enhances RA metabo- 
lism to inactive derivatives. Such actions would decrease the 
number of RA molecules in the nucleus. The experiments 
reported here support this second hypothesis. The presence 
of additional functional CRABP-I protein in the F9-Wt-S- 
CRABP-I-11  and F9-Wt-S-CRABP-I-15 transfected lines re- 
suits in lower induced levels of RAR 13, laminin B1, and col- 
lagen IV (cd) mRNAs (Figs. 4-6) and a smaller reduction 
in the level of REX-1  mRNA in response to RACT. More- 
over, the presence of a CRABP-I expression vector reduces 
the CAT transcription driven by the murine laminin B1 RARE 
in a transient expression system (Fig. 7 and 8). Finally, the 
presence of a CRABP-I expression vector partially prevents 
the transcriptional activation of the CAT gene by the RAR 
/3 RARE in a transient expression assay (Fig. 9). 
In contrast to the "early" gene RAR/3, the Era-1/Hox 1.6 
gene  is  not greatly affected by the  overexpression of the 
CRABP-I gene (Figs. 4 and 6). Although we do not under- 
stand the reason for this difference, one possibility is that the 
activation of the Era-1/Hox 1.6 gene is more sensitive to RA 
and its metabolites or RA:RAR complexes. It will be impor- 
tant to fully define the RA responsive regions of these two 
genes in order to help explain this difference. That the Era- 
1/Hox 1.6 gene is appropriately expressed under conditions 
in which laminin B1 and collagen type IV (cd) gene expres- 
sion is inhibited (Figs. 5 and 6) suggests that Era-1/Hox 1.6 
does not regulate the subsequent expression of laminin B1 or 
collagen type IV (or). Conversely, RAR/~ gene expression 
is reduced under conditions in which the expression of lami- 
nin B1 and collagen type IV (or) genes is reduced (Fig. 5 and 
6), consistent with prior findings that RARs can transactivate 
the laminin B1 RARE (Vasios  et al.,  1989). 
We had previously suggested that an appropriate level of 
functional  CRABP-I  protein was  necessary,  although  not 
sufficient, for F9 teratocarcinoma stem cell differentiation in 
response to RA (Stoner et al.,  1989; Wang et al.,  1984). 
This suggestion was based on the isolation of a differenti- 
ation-defective F9 mutant line, RA 3-10, that exhibited less 
than 5 % of  the level of functional CRABP-I protein observed 
in F9-Wt cells (Wang  et al.,  1984).  However, we have re- 
cently demonstrated that the differentiation defect in the RA 
3-10 mutant is not corrected by transfection of the wild type 
CRABP-I cDNA (Boylan, J., and L. Gudas, unpublished). 
Thus, the RA 3-10 mutation may not lie within the CRABP-I 
gene itself. For instance, a negative regulatory protein may 
be overexpressed in the RA 3-10 mutant line, resulting in 
both reduced expression of the CRABP-I gene and inhibition 
of the differentiation process. 
The F9-Wt-S-CRABP-I-15 cytoplasmic extract binds 10- 
25-fold more RA/mg protein than the  F9-Wt and F9-Wt- 
S-neo-I extracts  (Figs.  2  and  3).  If CRABP-I  sequesters 
RA, how much would a  10-fold increase in the number of 
CRABP-I molecules/cell reduce the free RA internal con- 
centration in F9 cells? The F9 differentiation model system is 
a complicated one, and the levels of internal RA, CRABP-I, 
and  RAR  /3  mRNA  all  change over time after the  addi- 
tion of RA to the culture medium. Detailed measurements 
of all of these parameters would be required to quantita- 
tively demonstrate the importance of CRABP-I in modu- 
lating the levels of free RA under a variety of conditions. 
Nevertheless, if we assume that a higher free RA concentra- 
tion within the cell results in more RA that is available for 
interaction with RARs in the nucleus, then an increase in the 
CRABP-I protein concentration within the cell should result 
in a decreased ability of the cell to differentiate in response 
to a given external RA concentration. This is generally what 
we observe. However, at very high external RA concentra- 
tions, most of the internal RA should be free in both the F9- 
Wt and F9-Wt-S-CRABP-I-15 lines. We do observe less inhi- 
bition  of differentiation in  the  F9-Wt-S-CRABP-I-15  line 
compared with the F9-Wt line at the highest exogenous RA 
concentration tested,  1  ×  10  -4 M  RA, consistent with this 
idea (Fig. 6). Conversely, at very low exogenous RA concen- 
trations (i.e.,  10  -tl to 10  -9 M),  we predict that most or all 
of the intracellular RA would be bound to the CRABP-I pro- 
tein in F9-Wt cells resulting in negligible or no activation of 
differentiation-specific  genes. However, at these very low ex- 
ternal RA concentrations the CRABP-I anti-sense transfec- 
tants should express differentiation markers to a greater ex- 
tent than F9-Wt ceils because the anti-sense transfectants 
have over 20-fold less  CRABP-I protein than F9-Wt cells 
(Fig. 2). We do observe a markedly greater activation of the 
laminin B1  and RAR/3  genes in the CRABP-I anti-sense 
transfectants than in the F9-Wt cells (Fig.  10),  but only at 
very  low  RA  concentrations  (1  x  10  -1°,  1  x  10  -9  M). 
Again, these results strongly support the general model that 
the  response of the cell to RA  varies  inversely with the 
CRABP-I level. 
CRABP-I mRNA and protein levels as well as RA levels 
have been assayed in sections of developing mouse and chick 
limbs  (Maden  et  al.,  1988,  1989;  Thaller  et  al.,  1987; 
Kwarta et al.,  1985; Tickle et al., 1982). Dolle et al. (1989) 
reported  that  CRABP-I  mRNA  was  expressed  along  a 
proximo-distal gradient with maximal expression in the most 
distal portion of the day 10 developing mouse limb. Dolle et 
al. (1989) also clearly showed that CRABP-I transcripts were 
excluded from regions of the day  14.5 developing mouse 
limb that express RAR 13 and RAR 3' transcripts. This strik- 
ing observation is consistent with the results reported here; 
CRABP-I expression may reduce a cell's ability to respond 
to RA, or even prevent a cell from responding to RA, de- 
pending on both the internal CRABP-I protein concentration 
and the external RA concentration to which the cell is ex- 
posed. Thus, in cells in the developing limb where RAR 3" 
and RAR j3 are expressed and a differentiation response to 
RA  is  presumably desired,  few CRABP-I  transcripts  are 
present. Conversely, in the more distal sections of the limb 
Boylan and Gudas CRABP-I  Decreases Retinoic Acid Differentiation  977 bud, where CRABP-I transcripts are high, no RA-associated 
differentiation response may be desired. 
We have provided evidence that the level of CRABP-I pro- 
tein  expression  can  profoundly  influence  the  degree  of 
differentiation in  response  to  RA.  We  suggest  that  the 
CRABP-I protein likewise indirectly regulates gene expres- 
sion in developing animals, either within the context of local 
RA  concentration gradients  or  possibly via  gradients  of 
CRABP-I itself. 
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